This article provides a comprehensive analysis of Hypoxia-Inducible Factor-1α (HIF-1α) as a master regulator of immune cell adaptation and dysfunction within the hypoxic Tumor Microenvironment (TME).
This article provides a comprehensive mechanistic and applied analysis of how immune checkpoint inhibitors (ICIs) overcome tumor-induced T-cell suppression to reactivate anti-cancer immunity.
This comprehensive review provides researchers, scientists, and drug development professionals with a critical head-to-head comparison of leading Cancer Stem Cell (CSC) isolation techniques.
This comprehensive review synthesizes current research on the gut microbiome's critical role in modulating patient response to immune checkpoint inhibitors (ICIs).
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on applying Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis to cancer...
This article provides a comprehensive analysis of Genetically Engineered Mouse Models (GEMMs) and patient-derived xenograft (PDX) models for immunotherapy research.
This article provides a comprehensive framework for researchers and drug development professionals to validate single-cell RNA sequencing (scRNA-seq) immune cell cluster annotations using flow cytometry.
This article provides researchers, scientists, and drug development professionals with a complete guide to the flow cytometry-based isolation of CD44+ CD133+ cancer stem cells (CSCs).
This article provides a detailed and up-to-date guide for researchers and drug development professionals on using flow cytometry for the immunophenotyping of Tumor-Infiltrating Lymphocytes (TILs).
This article provides a detailed examination of FDA guidance on master protocol trials in oncology, tailored for researchers and drug development professionals.